LI
Liontrust Investment Partners LLP disclosed a 5% stake in MXCT
Liontrust Investment Partners LLP reported owning 5% of Maxcyte, Inc. (MXCT) (5,194,322 shares) in a Schedule 13D filed Oct 15, 2026.
A 13D means the holder may push for changes at the company.